#DCLung25 is a 1-day, IASLC endorsed comprehensive lung cancer conference, Saturday, Oct 4th, Washington DC. A great time to visit our nation's capital & learn from the top lung cancer experts in the world! CME, MOC, nursing, pharmacy credits offered! medstarhealth.org/dclung25

This #WorldLungCancerDay, know your body and get symptoms checked. In most cases, it won't be cancer, but early diagnosis makes a difference. ScottishPower has pledged £4m for our Lung Cancer Centre of Excellence, bringing hope to those affected by lung cancer ♥️

Our #CancerAnnualReport reveals encouraging news about lung cancer: Incidence rates among men decreased in 2017–2021 for all races and ethnicities. Rates among women also decreased, but were stable among AI/AN females. acsjournals.onlinelibrary.wiley.com/doi/full/10.10… OncoAlert #WorldLungCancerDay

Dr Orem Jackson - ED,Uganda Cancer Institute We have found a unique partnership with PCAU. One of the ways to harness working together has been through such conferences that add value, come up with new areas of social and academic approaches to Cancer care. The UCI mandate is to

Newly published, #OpenAccess: In FLT3-TKD mutated acute myeloid leukemia, NPM1 co-mutation links to better survival. Patients without it face worse outcomes & may benefit from early stem cell transplant. Read on: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert Hagop Kantarjian,MD Naval Daver, M.D.

KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer dlvr.it/TMVKGH

We had a productive meeting with Ms. Nabukeera winnie, CEO of Little Winnie Foundation, to explore partnerships in strengthening #PalliativeCare human resource and soft skills training.

“In a plenary, a statement that really resonated with me was that PFS doesn’t automatically mean QOL.” In our latest CancerSpeak episode, Allison Rosen, MS shares her perspective on patient outcomes and early-onset cancer research at #ASCO25. cancerspeak.podbean.com/e/asco-2025-re… OncoAlert

NEW: FDA releases draft guidance on overall survival assessment in oncology trials, with an emphasis on analyzing overall survival as a pre-specified safety endpoint. fda.gov/regulatory-inf…

Following the development of crizotinib, newer generations of drugs have shown improved efficacy and reduced toxicity for patients with ROS1+ #NSCLC, allowing for more personalized treatment. Jorge Nieva Keck School of Medicine of USC #LCSM Read here: hubs.ly/Q03Ddx5x0

🩺 Many patients with advanced cancer report receiving treatment focused on living longer, even when they prefer comfort. New research in Cancer shows the importance of goal-aligned care: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… Manan Shah UCLA Jonsson Comprehensive Cancer Center The Patient-Centered Outcomes Research Institute OncoAlert @WileyOnc_Hem

We're honored to have leading experts guiding our discussions at the 16th Annual Ruesch Center Symposium! Register to engage with top minds in GI cancer and explore cutting-edge research. #GIcancer Georgetown Lombardi MedStar Georgetown Cure GI Cancers Register: hubs.li/Q03GgL1D0

This week's edition addresses the significant burden of bone cancer, a topic that demands attention. Further details are available in today's Daily Monitor Daily Monitor #FightCancerUg #UCIPCAUConf2025

Read the full The Wall Street Journal article in which our Chair of the Board and Past President Dr. Robin Zon is quoted, highlighting the "tremendous" advances in breast oncology.

All men are at risk for prostate cancer, but African American men are more likely to get prostate cancer and get it at a younger age than other men. Know the risk factors and talk to your doctor about next steps: bit.ly/425yJSv #prostatecancerawarenessmonth

Many elevated PSA levels normalize within a year, but consistently high values warrant direct diagnostic evaluation without repeated testing. ja.ma/488K3S3

Thank you Dr. Elizabeth Jaffee Johns Hopkins Kimmel Cancer Center for presenting the #GrandRounds Koenigsberg Lecture on the role of #cancervaccines in enhancing #antitumor immune responses in #cancer patients who have not yet benefited from immune #checkpointtherapy. Watch her full talk here

Read free in #CancerScope: A phase 2 trial in JAMA Oncology finds people with nonsurgical HPV-negative head & neck cancer may benefit from pre-radiation immunochemotherapy + chemo. 💊 86% saw tumor shrinkage ⚖️ Potential fewer side effects 🔗 acsjournals.onlinelibrary.wiley.com/doi/full/10.10… OncoAlert

Patient-reported outcomes, such as higher health status and lower symptom burden, are independently associated with improved overall survival in cancer patients. ja.ma/43MpzeQ

Uganda Cancer Institute has once again demonstrated its leadership and unwavering commitment to excellence after being crowned the BEST GOVERNMENT HEALTH INSTITUTION OF THE YEAR at the Visionaries of Uganda Awards, held at the Kampala Serena Hotel today. The prestigious ceremony was